Unbound MEDLINE

Cutaneous Vasculitis Associated With Interferon beta-1b Treatment for Multiple Sclerosis. Clinical neuropharmacology [Clin Neuropharmacol] Journal article

 
Szilasiová J, Gdovinová Z, Jautová J, Baloghová J, Ficová M, Bohuš P 
Cutaneous Vasculitis Associated With Interferon beta-1b Treatment for Multiple Sclerosis. [JOURNAL ARTICLE]
Clin Neuropharmacol 2009 September/October; 32(5):301-303.


We report a 38-year-old woman with relapsing-remitting multiple sclerosis, treated with subcutaneous injections of interferon beta (IFN-beta)-1b every other day. Disseminated cutaneous lesions were observed after 3 injections. These symptoms reappeared after drug readministration. The histopathological examination of the skin specimens confirmed nonspecific cutaneous lymphocytic vasculitis. The patient's outcome was favorable after corticosteroid placement and discontinuing IFN-beta therapy. Isolated lymphocytic cutaneous vasculitis linked to IFN-beta-1b therapy is suspected as a new association.



More from this journal
  
Advertise on this site.